Hospital bidding prices should be readjusted, KPMA says

Published: 2009-04-29 07:00:00

Updated: 2009-04-29 07:00:00

The Korea Pharmaceutical Manufacturers Association said the controversial hospital bidding drug prices should be controlled under the actually traded pricing system to prevent dual pricing of a same drug in hospital tender.

It argued pharmaceutical companies have no choice but to provide a cer...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK